Langmuir monolayer study toward combined antileishmanian therapy involving amphotericin B and edelfosine.

MLA

Hac-Wydro, Katarzyna, et al. “Langmuir Monolayer Study toward Combined Antileishmanian Therapy Involving Amphotericin B and Edelfosine.” The Journal of Physical Chemistry. B, vol. 113, no. 43, Oct. 2009, pp. 14239–46. EBSCOhost, https://doi.org/10.1021/jp9032996.

APA

Hac-Wydro, K., Dynarowicz-Łatka, P., & Zuk, R. (2009). Langmuir monolayer study toward combined antileishmanian therapy involving amphotericin B and edelfosine. The Journal of Physical Chemistry. B, 113(43), 14239–14246. https://doi.org/10.1021/jp9032996

Chicago

Hac-Wydro, Katarzyna, Patrycja Dynarowicz-Łatka, and Radosław Zuk. 2009. “Langmuir Monolayer Study toward Combined Antileishmanian Therapy Involving Amphotericin B and Edelfosine.” The Journal of Physical Chemistry. B 113 (43): 14239–46. doi:10.1021/jp9032996.